DaVita Inc (LTS:0I7E)
$ 146.8542 3.365 (2.37%) Market Cap: 11.89 Bil Enterprise Value: 23.00 Bil PE Ratio: 15.64 PB Ratio: 30.97 GF Score: 76/100

Q4 2018 DaVita Inc Earnings Call Transcript

Feb 14, 2019 / 02:00PM GMT
Release Date Price: $55.98
Operator

Thank you for standing by. My name is Colleen, and I will be your conference facilitator today. At this time, I would like to welcome everyone to DaVita Fourth Quarter 2018 Earnings Call. (Operator Instructions) Mr. Gustafson, you may begin your conference.

Jim Gustafson
DaVita Inc. - VP of IR

Thank you, Colin, and welcome, everyone, to our fourth quarter conference call. We appreciate your continued interest in our company. I'm Jim Gustafson, Vice President of Investor Relations. And with me today in the room are Kent Thiry, our CEO; Joel Ackerman, our CFO; Javier Rodriguez, CEO of DaVita Kidney Care; Jim Hilger, our Chief Accounting Officer; and LeAnne Zumwalt, Group Vice President.

Please note that during this call, we may make forward-looking statements within the meaning of the federal securities laws. All of these statements are subject to known and unknown risks and uncertainties that could cause the actual results to differ materially from those described in the forward-looking statements. For further details concerning these risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot